{
  "docId": "019dd923-622c-750b-8b99-65deaf51fc65",
  "docSlug": "41aa7e476e91",
  "documentTitle": "Xylem Inc. (XYL)",
  "authorId": "54_Spruce_Point_Capital",
  "authorName": "Spruce Point Capital Management",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2023-08-09 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 82,
  "pageCount": 82,
  "prevPage": 81,
  "nextPage": null,
  "slideType": "valuation_table",
  "function": "size_opportunity",
  "density": "dense",
  "nDataPoints": 32,
  "notes": "The slide uses a classic activist short-thesis structure: a bold thesis statement, a quantitative valuation bridge/table, and a list of supporting qualitative arguments.",
  "elementsJson": [
    "headline_text",
    "callout_box",
    "valuation_table",
    "bullet_list",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b99-65deaf51fc65/82",
  "deckHref": "/decks/019dd923-622c-750b-8b99-65deaf51fc65",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b99-65deaf51fc65.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b99-65deaf51fc65#slide-82",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.95,
        "x": 0.025,
        "y": 0.16
      },
      "kind": "callout",
      "text": "Spruce Point believes there is significant downside risk to Xylem's share price as its premium multiple is reconsidered by institutional investors in the face of abandoning its 2025 targets and the Evoqua acquisition at both an extreme valuation and under troubled circumstances. We believe the acquisition will further compound the loss of Xylem's credibility with the Street and its reputation can be severely damaged if the Department of Justice levies criminal charges against Evoqua. We see material downside to the share price and expect the stock to underperform both the S&P 500 and water sector.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "631d61a8-afc6-416a-9f8a-38749012c0e1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "Spruce Point believes there is significant downside risk to Xylem’s share price as its premium multiple is reconsidered by institutional investors in the face of abandoning its 2025 targets and the Evoqua acquisition at both an extreme valuation and under troubled circumstances.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-fb96-7553-b1cc-da11e8b7768f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.45,
        "x": 0.52,
        "y": 0.325
      },
      "kind": "list",
      "text": "Factors Why Xylem's Multiple Should Compress: Abrupt shift from 2025 goals, execution risk, liquidity strains, lack of transparency, accounting concerns, synergy quantification issues, and insider selling.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "846fe996-92af-47bc-acfd-3cc73ed3e6fc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Est. Share Price: 30% – 45%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-fb96-7553-b1cc-de5a753454ec",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.025,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "Source: Company financials, Spruce Point research",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "23489128-6c9e-4252-83f2-b8c98d640309",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.48,
        "x": 0.025,
        "y": 0.325
      },
      "kind": "table",
      "text": "Valuation table showing Low/Base case for Sales and EBITDA multiples resulting in share price downside.",
      "attrs": null,
      "subkind": "valuation",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c3c00a3e-3b27-465b-93bc-283ec5950c6d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.305,
        "y": 0.05
      },
      "kind": "title",
      "text": "Spruce Point Estimates 30% – 45% Downside",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c0400136-d3c9-427e-bdcd-c884f7fd032b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "valuation-bridge",
      "slug": null,
      "matchId": "81562580-e93e-430e-ad3f-fdc12b9b0500",
      "evidence": "The table calculates equity value and share price based on multiple compression scenarios.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 82,
      "from": 1,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "2fa1c508-68a2-4a6b-9e65-5ff630e9c720",
      "evidence": "The deck presents a detailed analysis of the risks and consequences of not taking action on Xylem's challenges",
      "position": 1,
      "objective": "Highlight the risks of not taking action",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}